난소적출 마우스에서 固眞飮子 물 추출물의 골다공증 개선 효과
Anti-osteoporotic Activity of Gojineumja Aqueous Extracts on the Ovariectomized Mice
4
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives: The objective of this in vivo study is to observe the anti-osteoporotic activities of Gojineumja aqueous extracts (GJEJ) on the ovariectomized (OVX) mice as compared to those of risedronate sodium (RES). Methods: Thirty five days after bilateral OVX, GJEJ was orally administered, for 35 days once a day and then the changes on the body weight and gain during experimental periods, femur weights, bone mineral density (BMD), bone strength (failure load), mineral contents - calcium (Ca) and inorganic phosphorus (IP), histological profiles and histomorphometrical analyses at sacrifice were conducted with serum biochemistry – osteocalcin contents and bone specific alkaline phosphatase (BALP) activities. And the results of GJEJ were compared with RES orally administered OVX mice. Results: As a result of OVX, noticeable increase of body weight and gains and serum osteocalcin levels, decrease of serum BALP activities, femur weights, femur Ca and IP contents, BMD and strength were observed as compared to those of sham control mice, respectively. Also, the decrease of all histomorphometrical indices indicating the bone mass and structure, and the increase of indices about resorption were also detected in the femur of OVX control. However, these estrogen-deficient osteoporotic signs were significantly and dose-dependently inhibited by 35 days of continuous oral treatment of GJEJ, at dose levels of 500, 250 and 125 mg/kg, respectively. Especially, GJEJ 500 mg/kg showed favorable inhibitory activities against estrogen- deficient osteoporosis symptoms induced by OVX as comparable to those of RES 2.5 mg/kg. Conclusions: The results in this study suggest that oral administrations of GJEJ have clear dose-dependent favorable anti-osteoporotic activities in OVX mice.
Abstract
Objectives: The objective of this in vivo study is to observe the anti-osteoporotic activities of Gojineumja aqueous extracts (GJEJ) on the ovariectomized (OVX) mice as compared to those of risedronate sodium (RES). Methods: Thirty five days after bilateral OVX, GJEJ was orally administered, for 35 days once a day and then the changes on the body weight and gain during experimental periods, femur weights, bone mineral density (BMD), bone strength (failure load), mineral contents - calcium (Ca) and inorganic phosphorus (IP), histological profiles and histomorphometrical analyses at sacrifice were conducted with serum biochemistry – osteocalcin contents and bone specific alkaline phosphatase (BALP) activities. And the results of GJEJ were compared with RES orally administered OVX mice. Results: As a result of OVX, noticeable increase of body weight and gains and serum osteocalcin levels, decrease of serum BALP activities, femur weights, femur Ca and IP contents, BMD and strength were observed as compared to those of sham control mice, respectively. Also, the decrease of all histomorphometrical indices indicating the bone mass and structure, and the increase of indices about resorption were also detected in the femur of OVX control. However, these estrogen-deficient osteoporotic signs were significantly and dose-dependently inhibited by 35 days of continuous oral treatment of GJEJ, at dose levels of 500, 250 and 125 mg/kg, respectively. Especially, GJEJ 500 mg/kg showed favorable inhibitory activities against estrogen- deficient osteoporosis symptoms induced by OVX as comparable to those of RES 2.5 mg/kg. Conclusions: The results in this study suggest that oral administrations of GJEJ have clear dose-dependent favorable anti-osteoporotic activities in OVX mice.
참고문헌 (48)
- Korean Society of Obstetrics and Gynecology, "Gynecology", pp.659~661 (2015), Korea Medical Publishing Company
- The Korean Association of Internal Medicine, "Harrison's Internal Medicine", pp.2883~2895 (2010), MIP publication
- Yamaguchi K, "Suppressive effect of norzoanthamine hydrochloride on experimental osteoporosis in ovariectomized mice", Biol Pharm Bull, 22(9), pp.920~924 (1999)
- Kang SG, "The Bibliographical Studies on the Acupuncture Treatment of the Osteoporosis", K.A.M.S, 15(2), pp.171~190 (1995)
- Kim HJ, "Literature Review of Menopausal osteoporosis", J Korean Obstet Gynecol, 11(1), pp.131~148 (1998)
- Lee C., "Introduction to Medicine(醫學入門)", pp.1892~ (2009), Bubin Publisher
- Huh J., "Dongeuibogam(東醫寶鑑)", pp.447~ (1966), Namsandang
- 강대원, "固眞飮子가 methotrexate로 유발된 흰쥐의 免役機能低下에 미치는 影響(영향)", 대한한방내과학회지, 25(4), pp.117~128 (2004), 대한한방내과학회
- 김현주, "固眞飮子가 Alzheimer Disease 병태모델의 신경세포 손상에 미치는 영향", 동의신경정신과학회지, 20(2), pp.31~46 (2009), 대한한방신경정신과학회
- Won CH, "Effect of Kojinyumja on galactosamine induced hepatotoxicity in rats", Dongguk J the Institute of Oriental Medicine, 6(1), pp.137~149 (1997)
- Lim DW, "Dried root of Rehmannia glutinosa prevents bone loss in ovariectomized rats", Molecules, 18(5), pp.5804~5813 (2013)
- Han N, "The in vivo effects of a fraction from Dioscorea spongiosa on glucocorticoid-induced osteoporosis", J Ethnopharmacol, 185, pp.53~59 (2016)
- Shin HD, "Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice", Nutrition, 23(11-12), pp.853~860 (2007)
- Joo JH, "A novel pyrazole derivative protects from ovariectomyinduced osteoporosis through the inhibition of NADPH oxidase", Sci Rep, 6, pp.22389~ (2016)
- Kang SJ, "Selection of the optimal herbal compositions of red clover and pomegranate according to their protective effect against climacteric symptoms in ovariectomized mice", Nutrients, 8(8), pp.447~ (2016)
- Harris ST, "Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group", JAMA, 282(14), pp.1344~1352 (1999)
- Nam SH, "Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model", Bone, 50(1), pp.149~155 (2012)
- Kang SJ, "Fermentation with Aquilariae Lignum enhances the antidiabetic activity of green tea in type II diabetic db", db mouse, 2014, pp.6(9), 3536~3571
- Choi JS, "Blood glycemia-modulating effects of melanian snail protein hydrolysates in mice with type II diabetes", Int J Mol Med, 39(6), pp.1437~1451 (2017)
- Manolagas SC, "Sex steroids and bone", Recent Prog Horm Res, 57, pp.385~409 (2002)
- Melton LJ 3rd, "How many women have osteoporosis?", J Bone Miner Res, 20(5), pp.886~892 (2005)
- Rodan GA, "Therapeutic approaches to bone diseases", Science, 289(5484), pp.1508~1514 (2000)
- Gowen M, "Emerging therapies for osteoporosis", Emerging Drugs, 5, pp.1~43 (2000)
- Devipriya N, "Effect of ellagic acid, a natural polyphenol, on alcoholinduced prooxidant and antioxidant imbalance: a drug dose dependent study", Singapore Med J, 48(4), pp.311~318 (2007)
- 김형수, "Single Oral Dose Toxicity Test of Blue Honeysuckle Concentrate in Mice", 한국독성학회지, 31(1), pp.61~68 (2015), 한국독성학회[DOI]
- Noh JR, "Hepatoprotective effect of Platycodon grandiflorum against chronic ethanolinduced oxidative stress in C57BL", 6 mice, 2011, pp.58(3), 224~231
- Editing commission of herbal medicine, "Bon-Cho-Hak(本草學)", pp.581~ (2011), Yeong-Rim-Sa
- 조창영, "肥兒丸이 난소적출로 유발된 흰쥐의 골다공증 모델에 미치는 영향", 한방재활의학과학회지, 27(2), pp.19~27 (2017), 한방재활의학과학회
- 김종현, "兎絲子가 卵巢摘出로 誘導된 흰쥐의 骨多孔症에 미치는 影響", 대한한방부인과학회지, 25(4), pp.1~11 (2012), 대한한방부인과학회
- Boonen S, "Preventing osteoporotic fractures with antiresorptive therapy:implications of microarchitectural changes", J Intern Med, 255(1), pp.1~12 (2004)
- Bae DC, "The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate", J Urol, 172(6 Pt 1), pp.2137~2144 (2004)
- Roux C, "Efficacy of risedronate on clinical vertebral fractures within six months", Curr Med Res Opin, 20(4), pp.433~439 (2004)
- Ito M, "Effects of risedronate on trabecular microstructure and biomechanical properties in ovariectomized rat tibia", Osteoporos Int, 16(9), pp.1042~1048 (2005)
- Lorden JF, "Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse", Neurobehav Toxicol Teratol, 8(5), pp.509~519 (1986)
- Bain SD, "High-dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse", J Bone Miner Res, 8(4), pp.435~442 (1993)
- Sandstedt J, "Elevated levels of growth hormone increase bone mineral content in normal young mice, but not in ovariectomized mice", Endocrinology, 137(8), pp.3368~3374 (1996)
- Andersson N, "Repeated in vivo determinations of bone mineral density during parathyroid hormone treatment in ovariectomized mice", J Endocrinol, 170(3), pp.529~537 (2001)
- Yamamoto M, "The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats", Endocrinology, 139(3), pp.1411~1419 (1998)
- Ederveen AG, "Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomyinduced bone loss in sexually mature rats", J Bone Miner Res, 14(11), pp.1963~1970 (1999)
- Ke HZ, "Long-term treatment of lasofoxifene preserves bone mass and bone strength and dose not adversely affect the uterus in ovariectomized rats", Endocrinology, 145(4), pp.1996~2005 (2004)
- Syed Z, "Bone densitometry : applications and limitations", J Obstet Gynaecol Can, 24(6), pp.476~484 (2002)
- Diez F, "Guidelines for the diagnosis of osteoporosis by densitometric methods", J Manipulative Physiol Ther, 25(6), pp.403~415 (2002)
- Tarvainen R, "Clodronate prevents immobilization osteopenia in rats", Acta Orthop Scand, 65(6), pp.643~646 (1994)
- Tanaka S, "Acute effects of ovariectomy on wound healing of alveolar bone after maxillary molar extraction in aged rats", Anat Rec, 262(2), pp.203~212 (2001)
- Heikkinen T, "Effects of long-term ovariectomy and estrogen treatment on maze learning in aged mice", Exp Gerontol, 39(9), pp.1277~1283 (2004)
- Jakubas-Przewlocka J, "Assessment of changes due to the long-term effect of estrogen and calcium deficiency in the trabecular bone structure in rats", Clin Exp Rheumatol, 23(3), pp.385~388 (2005)
- Murakami H, "Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy", J Bone Miner Res, 9(9), pp.1355~1364 (1994)
- Weinreb M, "Short-term healing kinetics of cortical and cancellous bone osteopenia induced by unloading during the reloading period in young rats", Virchows Arch, 431(6), pp.449~452 (1997)